Orchard Therapeutics plc Quarterly Interest Expense in USD from Q2 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Orchard Therapeutics plc quarterly/annual Interest Expense history and growth rate from Q2 2019 to Q3 2023.
  • Orchard Therapeutics plc Interest Expense for the quarter ending September 30, 2023 was $932K, a 16.6% increase year-over-year.
  • Orchard Therapeutics plc Interest Expense for the twelve months ending September 30, 2023 was $3.8M, a 34.2% increase year-over-year.
  • Orchard Therapeutics plc annual Interest Expense for 2022 was $3.08M, a 23.3% increase from 2021.
  • Orchard Therapeutics plc annual Interest Expense for 2021 was $2.5M, a 7.26% increase from 2020.
  • Orchard Therapeutics plc annual Interest Expense for 2020 was $2.33M, a 51.4% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $3.8M $932K +$133K +16.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $3.66M $975K +$303K +45.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $3.36M $957K +$282K +41.8% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $3.08M $933K +$250K +36.6% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-14
Q3 2022 $2.83M $799K +$116K +17% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $2.71M $672K +$79K +13.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $2.63M $675K +$137K +25.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $2.5M $683K +$108K +18.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $2.39M $683K +$111K +19.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.28M $593K +$25K +4.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $2.25M $538K -$75K -12.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $2.33M $575K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $572K -$88K -13.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $568K +$323K +132% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $613K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q3 2019 $660K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $245K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.